| Dr Amanda Deann Martin, DO | |
|
2004 Hayes St Ste 200, Nashville, TN 37203-2689 | |
| (615) 324-1600 | |
| (615) 324-1661 |
| Full Name | Dr Amanda Deann Martin |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 2004 Hayes St Ste 200, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134324825 | NPI | - | NPPES |
| 200583770A | Medicaid | OK | |
| 1134324825 | Medicaid | AL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Centennial Medical Center | Nashville, TN | Hospital |
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Tristar Horizon Medical Center | Dickson, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elite Sports Medicine And Orthopaedic Center Plc | 8729009634 | 69 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Researchers from North Carolina State University have developed an energy-efficient technique for accurately tracking a user's physical activity based on data from wearable devices.
The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.
VolitionRx Limited, a life sciences company focused on developing blood tests for a broad range of cancer types and other conditions, today announced the grant of US Patent Number 9,128,086 entitled "Detection of Histone Modification in Cell-Free Nucleosomes". This patent is already issued in Europe to the Company under the number EP1668368B1.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
› Verified 8 days ago
| Entity Name | Elite Sports Medicine And Orthopaedic Center Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528281623 PECOS PAC ID: 8729009634 Enrollment ID: O20051207000566 |
News Archive
Researchers from North Carolina State University have developed an energy-efficient technique for accurately tracking a user's physical activity based on data from wearable devices.
The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.
VolitionRx Limited, a life sciences company focused on developing blood tests for a broad range of cancer types and other conditions, today announced the grant of US Patent Number 9,128,086 entitled "Detection of Histone Modification in Cell-Free Nucleosomes". This patent is already issued in Europe to the Company under the number EP1668368B1.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Deann Martin, DO 101 Rockefeller Dr, Suite 101, Muskogee, OK 74401-5056 Ph: (918) 684-2663 | Dr Amanda Deann Martin, DO 2004 Hayes St Ste 200, Nashville, TN 37203-2689 Ph: (615) 324-1600 |
News Archive
Researchers from North Carolina State University have developed an energy-efficient technique for accurately tracking a user's physical activity based on data from wearable devices.
The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.
VolitionRx Limited, a life sciences company focused on developing blood tests for a broad range of cancer types and other conditions, today announced the grant of US Patent Number 9,128,086 entitled "Detection of Histone Modification in Cell-Free Nucleosomes". This patent is already issued in Europe to the Company under the number EP1668368B1.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
› Verified 8 days ago
Dr. Robert Joel Otto, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203 Phone: 615-342-0038 | |
James Hardman Rubright, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 345 23rd Ave N, Suite 212, Nashville, TN 37203 Phone: 615-963-9200 Fax: 615-963-9201 | |
Alexander David Savage, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203 Phone: 615-342-0038 | |
William Edward Carpenter, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8 City Blvd Ste 300, Nashville, TN 37209 Phone: 615-823-8891 Fax: 615-321-6226 | |
Daniel Nuri Kiridly, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3443 Dickerson Pike Ste 190, Nashville, TN 37207 Phone: 615-860-1580 | |
Dr. Chelsea Brown, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Dr. Jane Merideth Siegel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 21st Ave N, Nashville, TN 37203 Phone: 615-329-6600 Fax: 615-695-1483 |